MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Weight loss: FDA accepts EnteroMedics’ submission of VBLOC neurostim implant

Weight loss: FDA accepts EnteroMedics’ submission of VBLOC neurostim implant

By

Weight loss: FDA accepts EnteroMedics' submission of VBLOC neurostim implant

Minnesota medical devices maker EnteroMedics (NSDQ:ETRM) touted today that the FDA had accepted for review the company’s premarket approval submission of the Maestro Rechargeable System’s VBLOC implant, a neurostimulation device for treating obesity.

The news sent ETRM shares skyrocketing, trading up by nearly a quarter by the early afternoon today.

The VBLOC system stimulates the vagus nerve, located between the stomach and the esophagus, in order to alter a patient’s eating habits by modifying their physiological cravings.

Maestro delivers VBLOC therapy through 2 laparoscopically implanted leads that intermittently block the vagus nerves using high-frequency, low-energy electrical impulses. The therapy is powered by an internal battery, which is recharged via an external mobile charger and transmit coil that the patient uses for a short time each week.

Check out MassDevice’s Q&A with EnteroMedics CEO Mark Knudson and CFO Greg Lea

"The Maestro System holds the potential to fill a significant gap in the obesity treatment landscape, offering a unique, patient-friendly approach to addressing the long term challenges associated with obesity," EnteroMedics president & CEO Mark Knudson said in prepared remarks. "We look forward to working closely with the FDA during the review process, continuing through an advisory committee panel and approval decision, as we prepare for U.S. commercialization of the Maestro System."

The Maestro system has been on the European market since winning CE Mark approval in 2011.

ETRM shares were trading at $1.29 as of about 12:40 p.m., up 21.5% on the day.

In case you missed it

RSS From Medical Design & Outsourcing

  • Ahead of G7 launch, Dexcom CEO plans for ‘more activity than we’ve ever seen’ in 2022
    With a major product approval and launch in its sights, Dexcom prepares for a big year in 2022. Across 2021, Dexcom (NSDQ:DXCM) took several steps forward. The company touted its next-generation G7 continuous glucose monitor (CGM) and announced a major regulatory nod and partnership for real-time application programming interfaces (APIs), to list a couple. As the new year gets underway, expectations for the… […]
  • Former Zimmer Biomet executive has a new job
    Carrie Nichol, the former chief accounting officer of Zimmer Biomet (NYSE:ZBH), has a new job outside of the medtech industry. Nichol, who also served as vice president, controller and principal accounting officer at Zimmer Biomet, is now a VP and controller at Minnetonka, Minnesota-based Cargill. Her departure was among the many notable medtech executive moves… […]
  • Employees say Intuitive, Boston Scientific, J&J, Medtronic are among the best places to work in 2022
    Intuitive Surgical, Boston Scientific, Johnson & Johnson and Medtronic were recently named by Glassdoor as Best Places to Work in 2022 based on employee reviews. Each year, Glassdoor uses feedback that employees have shared on the website over the past 12 months to compile a list of the best places to work for the upcoming… […]
  • Medtronic’s M&A strategy explained by CFO Karen Parkhill
    When Medtronic CFO and EVP Karen Parkhill looks back at the medical device manufacturer’s performance through the COVID-19 pandemic, she recalls a key decision that rankled investors but paid off in the long run. “When I first joined Medtronic, it was shortly after the Covidien merger and we had taken on a lot of debt… […]
  • Loftware acquires Prisym ID
    Loftware announced that it acquired Prisym ID, a provider of regulated content and label management solutions. Prisym ID focuses on clinical trials, medical device and pharmaceutical labeling, with the acquisition set to expand Loftware’s enterprise labeling solution offerings for the medical device and pharmaceutical industries while enhancing Loftware’s end-to-end, cloud-based labeling platform with advanced clinical… […]
  • BD, Pfizer, Wellcome want to improve hospitals’ antimicrobial practices
    BD (NYSE:BDX) announced yesterday that it will collaborate with Pfizer (NYSE:PFE) and Wellcome to advance antimicrobial stewardship practices. The collaboration builds on ongoing efforts to advance the role of diagnostics in addressing the challenge of antimicrobial resistance (AMR), according to a news release. The companies will survey existing diagnostic practices to highlight benefits and gaps… […]
  • iRhythm CEO considers costs on the path to profitability
    Fresh off positive reimbursement news for its Zio remote external electrocardiogram monitoring device, the CEO of iRhythm Technologies (NSDQ:IRTC) doesn’t just have revenue on his mind. iRhythm President and CEO Quentin Blackford — the former Dexcom COO who replaced Mike Coyle in September — said his company will need to keep costs under control as it… […]
  • Integer Holdings makes additions to its executive team
    Integer Holdings today announced that it has appointed three new executives to its leadership team. The appointments come as part of a planned transition due to retirements. Margaret Cathy is being promoted to senior VP of quality and regulatory affairs; Andrew Senn is being promoted to senior VP of strategy and business development and McAlister… […]
  • Healthcare venture funding boomed in 2021; expect a slowdown in 2022
    An all-time-high $86 billion of venture capital investments in the U.S. and Europe last year bested 2020’s record haul by more than 30% and grew more than 150% from 2019, according to a new analysis by Silicon Valley Bank. After record-setting quarters in the first half, however, VC investment slowed due to poor performing biopharma… […]
  • Medical technical writers vs. medical writers: What’s the difference?
    By CfPIE Pharmaceutical organizations often have trouble conveying complex medical concepts to “layman” users like patients and the public. Being able to communicate medical device usage instructions, clinical trial results, patient education materials, and other important materials is essential for end-users to get the most out of your products and services while preventing potential health… […]
  • Traco Power touts new encapsulated AC/DC power supplies
    Traco Power this week announced it launched its new TPP 40E and TPP 65E miniature encapsulated AC/DC power supplies. The new AC/DC power supplies have safety approvals for both medical and industrial applications. Each wattage family has six models, offering single outputs of 5, 12, 15, 24, 36, 48V with up to 94% efficiency, according… […]

Leave a Reply